ArticleJournal of translational medicine2026
MaR1 and NGF combine to inhibit autophagy through the GSK-3β/β-catenin pathway to promote sciatic nerve repair.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeripheral nerve injury (PNI) is a public health problem that can lead to sensory and motor deficits as well as neuropathic pain and secondary lesions. We explored the effects of the combination of MaR1 and NGF on sciatic nerve regeneration, reduction of neuropathic pain, and anti-inflammation, and further elucidated the associated molecular mechanisms.
methodsAfter treatment of PC12 (adrenal pheochromocytoma cells) cells with NGF, MaR1 and H₂O₂, changes in proliferation were detected by CCK8; cell migration ability was detected by Transwell; reactive oxygen species (ROS) and apoptosis were detected by flow cytometry; and the mRNA expression of the inflammatory factors IL-1β, IL-6, and TNF-α was detected by qRT-PCR. Western blot detected the protein expression of β-catenin, P62, GSK-3β, LC3B, NF200, S100, MBP; Immunofluorescence analysis of LC3B expression; During recovery experiments, observe changes following treatment with GSK-3β activators and the autophagy agonist rapamycin. PNI model was constructed using 6-week-old male SD rats, NGF, MaR1 or saline was injected locally, and the drug was administered 3 times on alternate days after surgery, sciatic nerve function index analysis and muscle atrophy test were performed after surgery; the gastrocnemius muscle wet weight ratio and HE staining were observed after the samples were taken after surgery, and NF200, S100, MBP, β-catenin, and P62 were detected by Western blot, GSK-3β, LC3B levels; the expression of NF200, β-catenin, P62, GSK-3β, LC3B was detected by immunohistochemistry.
resultsNGF and MaR1 were non-toxic and the combination of NGF and MaR1 increased the proliferation and migration of PC12 cells, reduced H₂O₂ induced ROS production, inhibited apoptosis, and had a significant anti-inflammatory effect. In vivo studies showed that MaR1 and NGF combined could more effectively promote nerve repair and recovery of sensory and motor functions in SD rats, and reduce gastrocnemius muscle atrophy.The combination of MaR1 and NGF inhibited autophagy through GSK-3β/β-catenin signaling pathway to regulate the growth and repair of sciatic nerve. And the GSK-3β agonist DIF-3 and the autophagy activator rapamycin antagonize this effect.
conclusionThe combination of MaR1 and NGF promotes sciatic nerve repair and motor function recovery and reduces local inflammation by inhibiting autophagy through the GSK-3β/β-catenin pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.